Afternoon Market Losers
June 21, 2013 at 13:20 PM EDT
Idenix Pharmaceuticals (NASDAQ: IDIX ) plunged 28.65 percent to $3.66 after the US Food and Drug Administration requested additional preclinical safety information for its IDX20963. Ebix (NASDAQ: EBIX ) dipped 17.06 percent to $9.12 as Ebix and an affiliate of Goldman Sachs (NYSE: GS ) announced
